Proteomic analysis of zebrafish (Danio rerio) embryos exposed to cyclosporine A

Journal of Proteomics

Volumn 75, Issue 3, 2012, Pages 1004-1017

  Ponnudurai, Ruby P ^a   Basak, Trayambak ^a   Ahmad, Shadab ^a   Bhardwaj, Gourav ^a   Chauhan, Rajendra K ^a   Singh, Ramcharan A ^a   Lalwani, Mukesh Kumar ^a   Sivasubbu, Sridhar ^a   Sengupta, Shantanu ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

2D DIGE; Actin; Calcineurin; Cyclosporine; Zebrafish

Indexed keywords

ACTIN; CREATINE KINASE; CYCLOSPORIN A; ENOLASE 1; ENOLASE 3; FAST SKELETAL MUSCLE MYOSIN LIGHT POLYPEPTIDE 3; HSPA8 PROTEIN; HSPD1 PROTEIN; HYPOTHETICAL PROTEIN PPA1; LIPID BINDING PROTEIN; MESSENGER RNA; MITOCHONDRIAL ATP SYNTHASE BETA SUBUNIT LIKE HYPOTHETICAL PROTEIN; MYOSIN LIGHT CHAIN 2; NUCLEOSIDE DIPHOSPHATE KINASE Z1; PARVALBUMIN 2; PROTEIN; TROPOMYOSIN 3; UNCLASSIFIED DRUG; VG1 PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD REGURGITATION; CIRCULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; EDEMA; EMBRYO; GENE EXPRESSION; GENETIC ANALYSIS; GERM LINE; MASS SPECTROMETRY; METABOLISM; MICROSCOPY; MORPHOGENESIS; NONHUMAN; PERICARDIUM; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; STRESS; TIME LAPSE IMAGING; TRANSGENIC ANIMAL; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; WESTERN BLOTTING; YOLK SAC; ZEBRA FISH;

ABNORMALITIES, MULTIPLE; ANIMALS; CYCLOSPORINE; EMBRYO, NONMAMMALIAN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MORPHOGENESIS; PREGNANCY; PROTEOME; PROTEOMICS; ZEBRAFISH; ZEBRAFISH PROTEINS;

DANIO RERIO;

EID: 84355161958     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.10.016     Document Type: Article

References (56)

1. Kahan B.D. Cyclosporine: the agent and its actions. Transplant Proc 1985, 17:5-18.
2. Moorman M.T., Epstein R.B., Smith J.W., O'Neal C., Holter J.L. Management of cyclosporine overdose in a hematopoietic stem cell transplant patient with sequential plasma exchange and red blood cell exchange. J Clin Apher 2011, 26(3):156-158.
3. Sayin R., Soyoral Y.U., Erkoc R. Polyneuropathy due to cyclosporine A in patients with renal transplantation: a case report. Ren Fail 2011, 33(5):528-530.
4. Czolpinska K., MacDonald A.S., Williams C.N. Cyclosporin A therapy of Crohn's disease. Clin Invest Med 1987, 137:799-802.
5. Gupta S., Keshavarzian A., Hodgson H.J. Cyclosporin in ulcerative colitis. Lancet 1984, 2:1277-1278.
6. Bray G.P., Williams R. Immunointervention in primary biliary cirrhosis: an overview. J Autoimmun 1992, 5(Suppl. A):293-300.
7. Mackenzie I.L., Manoharan A. Cyclosporine A in the treatment of aplastic anemia. Am J Hematol 1988, 28:211-216.
8. Tugwell P. Cyclosporin in the treatment of rheumatoid arthritis. J Autoimmun 1992, (Suppl. A):231-240.
9. Bang D. Treatment of Behçet's disease. Yonsei Med J 1997, 38:401-410.
10. Elkharrat D., Goulon M., Gajdos P. Cyclosporine for myasthenia gravis. N Engl J Med 1987, 317:770-778.
11. Lueck C.J., Trend P., Swash M. Cyclosporin in the management of polymyositis and dermatomyositis. J Neurol Neurosurg Psychiatry 1991, 54:1007-1008.
12. Flanagan M.W., Corthesy B., Bram R.J., Crabtree G.R. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporine A. Nature 1991, 352:803-807.
13. Al-Daraji W.I., Grant K.R., Ryan K., Saxton A., Reynold N.J. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A. J Invest Dermatol 2002, 118:779-788.
14. Schulz R.A., Yutzey K.E. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev Biol 2004, 266:1-14.
15. Serfling E., Klein-Hessling S., Palmetshofer A., Bopp T., Stassem M., Schmitt E. NFAT transcription factors in control of peripheral T cell tolerance. Eur J Immunol 2006, 36:2837-2843.
16. Nguyen T., Di Giovanni S. NFAT signaling in neural development and axon growth. Int J Dev Neurosci 2008, 26:141-145.
17. Crabtree G.R. Generic signals and specific outcomes: signalling through Ca2+, calcineurin, and NF-AT. Cell 1999, 96:611-614.
18. Ho S., Clipstone N., Timmermann L., Northrop J., Graef I., Fiorentino D., et al. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 1996, 80:S40-S45.
19. Rezzani R. Cyclosporine A and adverse effects on organs. Prog Histochem Cytochem 2004, 39:85-128.
20. Zoja C., Furci L., Ghilardi F., Zilio P., Benigni A., Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest 1986, 55:455-462.
21. Abbott K.L., Friday B.B., Thaloor D., Murphy T.J., Pavlath G.K. Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. Mol Biol Cell 1998, 9:2905-2916.
22. Robida A.M., Xu K., Ellington M.L., Murphy T.J. Cyclosporin A selectively inhibits mitogen-induced cyclooxygenase-2 gene transcription in vascular smooth muscle cells. Mol Pharmacol 2000, 58:701-708.
23. Ohkawa Y., Hayashi K., Sobue K. Calcineurin-mediated pathway involved in the differentiated phenotype of smooth muscle cells. Biochem Biophys Res Commun 2003, 301:78-83.
24. Janssen P.M., Zeitz O., Keweloh B., Siegel U., Maier L.S., Barckhausen P., et al. Influence of cyclosporine A on contractile function, calcium handling, and energetics in isolated human and rabbit myocardium. Cardiovasc Res 2000, 47:99-107.
25. Suzuki M. Children's toxicology from to bed-drug-induced renal injury (4): effects of nephrotoxic compounds on fetal and developing kidney. J Toxicol Sci 2009, 34:267-271.
26. Flechner S.M., Katz A.R., Rogers A.J., VanBuren C., Kahan B.D. The presence of ciclosporine in body tissues and fluids during pregnancy. Am J Kidney Dis 1985, 5:60-63.
27. Miniero R., Tardivo I., Curtoni E.S., Segoloni G.P., La Rocca E., Nino A., et al. Pregnancy after renal transplantation in Italian patients: focus on fetal outcome. J Nephrol 2002, 15:626-632.
28. Sgro M.D., Barozzino T., Mirghani H.M., Sermer M., Moscato L., Akoury H., et al. Pregnancy outcome post renal transplantation. Teratology 2002, 65:5-9.
29. Uhing M.R., Goldman A.S., Goto M.P. Cyclosporin A-induced embryopathy in embryo culture is mediated through inhibition of the arachidonic acid pathway. Proc Soc Exp Biol Med 1993, 202:307-314.
30. Rezzani R., Rodella L., Bianchi R. Cyclosporine and pregnancy in the rat. Transplantation 1997, 63:164-167.
31. Tendron A., Decramer S., Justrabo E., Gouyon J.B., Semama D.S., Gilbert T. Cyclosporin A administration during pregnancy induces a permanent nephron deficit in young rabbits. J Am Soc Nephrol 2003, 14:3188-3196.
32. Liberatore C.M., Yutzey K.E. Calcineurin signaling in avian cardiovascular development. Dev Dyn 2004, 229:300-1129.
33. Pompa D., Timmerman L.A., Takimoto H., Yoshida H., Elia A.J., Samper E., et al. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 1998, 392:182-186.
34. Chang C.P., Neilson J.R., Bayle J.H., Gestwicki J.E., Kuo A., Stankunas K., et al. A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis. Cell 2004, 118:649-663.
35. Beis D., Bartman T., Jin S.W., Scott I.C., D'Amico L.A., Ober E.A., et al. Genetic and cellular analyses of zebrafish atrioventricular cushion and valve development. Development 2005, 132:4193-4204.
36. Klawitter J., Klawitter J., Kushner E., Jonscher K., Bendrick-Peart J., Leibfritz D., et al. Association of immunosuppressant-induced protein changes in the rat kidney with changes in urine metabolite patterns: a proteo-metabonomic study. J Proteome Res 2010, 9:865-875.
37. Stainier D.Y. Zebrafish genetics and vertebrate heart formation. Nat Rev Genet 2001, 2:39-48.
38. Westerfield M. The Zebrafish book. A guide for the laboratory use of Zebrafish (Danio rerio) 2004, Univ. of Oregon Press, Eugene.
39. Pickart M.A., Klee E.W., Nielsen A.L., Sivasubbu S., Mendenhall E.M., Bill B.R., et al. Genome-wide reverse genetics framework to identify novel functions of the vertebrate secretome. PLoS One 2006, 1:e104.
40. Lieschke G.J., Oates A.C., Crowhurst M.O., Ward A.C., Layton J.E. Morphological and functional characterization of granulocytes and macrophages in embryonic and adult zebrafish. Blood 2001, 98(10):3087-3096.
41. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29(9):e45.
42. Liao W., Bisgrove B.W., Sawyer H., Hug B., Bell B., Peters K., et al. The zebrafish gene cloche acts upstream of a flk-1 homologue to regulate endothelial cell differentiation. Development 1997, 124:381-389.
43. Lawson N.D., Scheer N., Pham V.N., Kim C.H., Chitnis A.B., Campos-Ortega J.A., et al. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 2001, 128:3675-3683.
44. Buschmann I.R., Lehmann K., Le Noble F. Art. Net. Physics meets molecules: is modulation of shear stress the link to vascular prevention?. Circ Res 2008, 102(5):510-512.
45. Ordahl C.P. The skeletal and cardiac α-action genes are coexpressed in early embryonic striated muscle. Dev Biol 1986, 117:488-492.
46. Kumar A., Crawford K., Close L., Madison M., Lorenz J., Doetschman T., et al. Rescue of cardiac a-actin-deficient mice by enteric smooth muscle g-actin. Proc Natl Acad Sci 1997, 94:4406-4411.
47. Mitchell J.W., Mitchell J.J., Low R.B., Kieny M., Sengel P., Rubbia L., et al. α-Smooth muscle actin is transiently expressed in embryonic rat cardiac and skeletal muscles. Differentiation 1988, 39:161-166.
48. Graef I.A., Chen F., Chen L., Kuo A., Crabtree G.R. Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern calcineurin B1 is essential for the developing vasculature. Cell 2001, 105:863-875.
49. Sassoon D.A., Garner I., Buckingham M.D. Transcripts of alpha-cardiac and alpha-skeletal actins are early markers for myogenesis in the mouse embryo. Development 1988, 104:155-164.
50. Costa M.L., Escaleira R.C., Rodrigues V.B., Manasfi M., Mermelstein C.S. Some distinctive features of Zebrafh myogenesis based on unexpected distributions of the muscle cytoskeletal proteins actin, myosin, desmin, α-actinin, troponin and titin. Mech Dev 2002, 116:95-104.
51. Zheng X.L., Wong N.C. Cyclosporin A inhibits apolipoprotein AI gene expression. J Mol Endocrinol 2006, 37:367-373.
52. Kheirollah A., Ito J., Nagayasu Y., Lu R., Yokoyama S. Cyclosporin A inhibits apolipoprotein A-I-induced early events in cellular cholesterol homeostasis in rat astrocytes. Neuropharmacology 2006, 51:693-700.
53. Le Goff W., Peng D.Q., Settle M., Brubaker G., Morton R.E., Smith J.D. Cyclosporin A traps ABCA1 at the plasma membrane and inhibits ABCA1-mediated lipid efflux to apolipoprotein A-I. Arterioscler Thromb Vasc Biol 2004, 24:2155-2161.
54. Zheng X.L., Wong N.C. Cyclosporin A inhibits apolipoprotein AI gene expression. J Mol Endocrinol 2006, 37:367-373.
55. Puigmulé M., López-Hellin J., Suñé G., Tornavaca O., Camaño S., Tejedor A., et al. Differential proteomic analysis of cyclosporine A-induced toxicity in renal proximal tubule cells. Nephrol Dial Transplant 2009, 24:2672-2686.
56. Pancholi V. Multifunctional a-enolase: its role in diseases. Cell Mol Life Sci 2001, 58:902-920.